ARTG 426050NxStage PureFlow SL - Dialysate delivery system, haemodialysis, single patient
ARTG ID: 426050 · Fresenius Medical Care Australia Pty Ltd · NxStage Medical Inc · Class IIb · Started October 18, 2023
Good Name: Fresenius Medical Care Australia Pty Ltd - NxStage PureFlow SL - Dialysate delivery system, haemodialysis, single patient
- Risk Class
- Class IIb
- Product Type
- Medical device system
- ARTG Category
- General
- ARTG ID
- 426050
- Start Date
- October 18, 2023
- Effective Date
- October 18, 2023
- Country
- United States of America
- Address
- 350 Merrimack Street, Lawrence, MA, 01843
The NxStage PureFlow SL uses potable water to prepare dialysates for haemodialysis therapy and monitors and controls the delivery of the dialysate to the NxStage heamodialysis cycler.
Access comprehensive regulatory information for NxStage PureFlow SL - Dialysate delivery system, haemodialysis, single patient in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIb is registered under ARTG number 426050 and sponsored by Fresenius Medical Care Australia Pty Ltd, manufactured by NxStage Medical Inc in United States of America. The device registration started on October 18, 2023.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.